Bristol-Myers Squibb Co (BMY)
48.92
+0.62
(+1.28%)
USD |
NYSE |
Apr 19, 16:00
48.93
+0.01
(+0.02%)
After-Hours: 18:14
Bristol-Myers Squibb Price to Book Value: 3.361 for April 19, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 3.319 |
| April 17, 2024 | 3.287 |
| April 16, 2024 | 3.316 |
| April 15, 2024 | 3.333 |
| April 12, 2024 | 3.317 |
| April 11, 2024 | 3.375 |
| April 10, 2024 | 3.456 |
| April 09, 2024 | 3.546 |
| April 08, 2024 | 3.511 |
| April 05, 2024 | 3.526 |
| April 04, 2024 | 3.532 |
| April 03, 2024 | 3.585 |
| April 02, 2024 | 3.624 |
| April 01, 2024 | 3.641 |
| March 28, 2024 | 3.726 |
| March 27, 2024 | 3.659 |
| March 26, 2024 | 3.611 |
| March 25, 2024 | 3.590 |
| March 22, 2024 | 3.568 |
| March 21, 2024 | 3.545 |
| March 20, 2024 | 3.565 |
| March 19, 2024 | 3.559 |
| March 18, 2024 | 3.545 |
| March 15, 2024 | 3.596 |
| March 14, 2024 | 3.607 |
| Date | Value |
|---|---|
| March 13, 2024 | 3.618 |
| March 12, 2024 | 3.738 |
| March 11, 2024 | 3.735 |
| March 08, 2024 | 3.696 |
| March 07, 2024 | 3.661 |
| March 06, 2024 | 3.668 |
| March 05, 2024 | 3.561 |
| March 04, 2024 | 3.499 |
| March 01, 2024 | 3.497 |
| February 29, 2024 | 3.487 |
| February 28, 2024 | 3.499 |
| February 27, 2024 | 3.471 |
| February 26, 2024 | 3.471 |
| February 23, 2024 | 3.550 |
| February 22, 2024 | 3.527 |
| February 21, 2024 | 3.498 |
| February 20, 2024 | 3.426 |
| February 16, 2024 | 3.426 |
| February 15, 2024 | 3.397 |
| February 14, 2024 | 3.359 |
| February 13, 2024 | 3.347 |
| February 12, 2024 | 3.418 |
| February 09, 2024 | 3.422 |
| February 08, 2024 | 3.347 |
| February 07, 2024 | 3.342 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.034
Minimum
Mar 23 2020
8.520
Maximum
Dec 27 2019
4.044
Average
3.973
Median
Sep 01 2021
Price to Book Value Benchmarks
| Amgen Inc | 23.13 |
| Gilead Sciences Inc | 3.641 |
| Johnson & Johnson | 5.182 |
| Karuna Therapeutics Inc (DELISTED) | 10.05 |
| 2seventy bio Inc | 0.9105 |
Price to Book Value Related Metrics
| PE Ratio | 12.67 |
| PS Ratio | 2.259 |
| PEG Ratio | 0.4108 |
| Price to Free Cash Flow | 8.035 |
| Price | 48.92 |
| Earnings Yield | 7.89% |
| Market Cap | 98.93B |
| PEGY Ratio | 0.3551 |
| Operating PE Ratio | 12.40 |
| Normalized PE Ratio | 12.91 |